These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28190783)

  • 1. A retrospective analysis of catheter-based sources in intravascular brachytherapy.
    DeCunha J; Janicki C; Enger SA
    Brachytherapy; 2017; 16(3):586-596. PubMed ID: 28190783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new delivery system to resolve dosimetric issues in intravascular brachytherapy.
    DeCunha JM; Enger SA
    Brachytherapy; 2018; 17(3):634-643. PubMed ID: 29519606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving patient-specific dosimetry for intravascular brachytherapy.
    Li XA; O'Neill M; Suntharalingam M
    Brachytherapy; 2005; 4(4):291-7. PubMed ID: 16344260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of late lumen loss after antiproliferative percutaneous coronary intervention using beta-irradiation in a porcine model of restenosis.
    Deiner C; Loddenkemper C; Rauch U; Rosenthal P; Pauschinger M; Schwimmbeck PL; Schultheiss HP; Pels K
    Cardiovasc Revasc Med; 2007; 8(2):94-8. PubMed ID: 17574167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose effects of stents in intravascular brachytherapy for in-stent restenosis: a Monte Carlo calculation.
    Li XA
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):842-8. PubMed ID: 12573772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta versus gamma for catheter-based intravascular brachytherapy: dosimetric perspectives in the presence of metallic stents and calcified plaques.
    Li XA; Wang R; Yu C; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):1043-9. PubMed ID: 10705028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis.
    Feres F; Muñoz JS; Abizaid A; Albertal M; Mintz GS; Staico R; Centemero M; Mattos LA; Maldonado G; Tanajura LF; Chaves A; Pinto I; Abizaid AS; Seixas AC; Vaz VD; Sousa A; Sousa JE
    Am J Cardiol; 2005 Dec; 96(12):1656-62. PubMed ID: 16360353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravascular brachytherapy for peripheral vascular disease.
    Andras A; Hansrani M; Stewart M; Stansby G
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003504. PubMed ID: 24399686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravascular brachytherapy using 90Sr for saphenous vein grafts having diameters ranging from 2.0-5.0 mm.
    Mignano JE; Rivard MJ
    Brachytherapy; 2004; 3(3):173-8. PubMed ID: 15533810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium neutron capture brachytherapy (GdNCB), a new treatment method for intravascular brachytherapy.
    Enger SA; Rezaei A; Munck af Rosenschöld P; Lundqvist H
    Med Phys; 2006 Jan; 33(1):46-51. PubMed ID: 16485408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracoronary radiotherapy with a (188)rhenium liquid-filled PTCA balloon system in in-stent restenosis: acute and long-term angiographic results, as well as 1-year clinical follow-up.
    Reynen K; Köckeritz U; Kropp J; Wunderlich G; Knapp FF; Schmeisser A; Strasser RH
    Int J Cardiol; 2004 May; 95(1):29-34. PubMed ID: 15159034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetry study for beta-radiation treatment of in-stent restenosis.
    Chu CH; Hsieh BT; Chen IJ; Chen WL; Lin UT
    Radiat Prot Dosimetry; 2009 Feb; 134(1):49-54. PubMed ID: 19376885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods to improve dose uniformity for radioactive stents in endovascular brachytherapy.
    Amols HI
    Cardiovasc Radiat Med; 1999; 1(3):270-7. PubMed ID: 11272372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorbed dose assessment of cardiac and other tissues around the cardiovascular system in brachytherapy with 90Sr/90Y source by Monte Carlo simulation.
    Saghamanesh S; Karimian A; Abdi M
    Radiat Prot Dosimetry; 2011 Sep; 147(1-2):296-9. PubMed ID: 21831866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and determinants of the long-term beta intracoronary brachytherapy results.
    Witkowski A; Kalińczuk Ł; Chmielak Z; Łyczek J; Pregowski J; Kawczyńska M; Bulski W; Kulik A; Kepka C; Kruk M; Pszona S; Rózyłło W
    Kardiol Pol; 2005 Jun; 62(6):545-557; discussion 558. PubMed ID: 16123848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a positron emitting V48 nitinol stent for intracoronary brachytherapy.
    Li AN; Eigler NL; Litvack F; Whiting JS
    Med Phys; 1998 Jan; 25(1):20-8. PubMed ID: 9472822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose effect of guidewire position in intravascular brachytherapy.
    Shih R; Hsu WL; Li XA
    Phys Med Biol; 2002 May; 47(10):1733-40. PubMed ID: 12069090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment planning dosimetric parameters for a (90)Y coil source used in intravascular brachytherapy.
    Patel NS; Chiu-Tsao ST; Fan P; Ahunbay E; Ravi K; Sherman W; Quon H; Pisch J; Tsao HS; Harrison LB
    Cardiovasc Radiat Med; 2001; 2(2):83-92. PubMed ID: 11340012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric measurements in isolated human coronary arteries: comparison of commercially available iridium(192) with strontium/yttrium(90) emitters.
    Hanefeld C; Amirie S; Borchardt D; Grewe P; Müller KM; Kissler M; Mügge A
    Circulation; 2002 May; 105(21):2493-6. PubMed ID: 12034655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo calculations of dose distributions around 32P and 198Au stents for intravascular brachytherapy.
    Reynaert N; Verhaegen F; Taeymans Y; Van Eijkeren M; Thierens H
    Med Phys; 1999 Aug; 26(8):1484-91. PubMed ID: 10501047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.